Virologic and Immunologic Outcomes of the Second-Line Regimens of Antiretroviral Therapy Among HIV-Infected Patients in Thailand (Q39597533)

13 September 2017

title

Virologic and Immunologic Outcomes of the Second-Line Regimens of Antiretroviral Therapy Among HIV-Infected Patients in Thailand (English)

1 reference

Sasisopin Kiertiburanakul

13 September 2017

0 references

0 references

anti-retroviral agent

0 references

author

4

object named as

Sasisopin Kiertiburanakul

1 reference

13 September 2017

Somnuek Sungkanuparph

5

object named as

Somnuek Sungkanuparph

1 reference

13 September 2017

May Myat Win

1

1 reference

13 September 2017

Wirach Maek-A-Nantawat

2

1 reference

13 September 2017

Benjaluck Phonrat

3

1 reference

13 September 2017

publication date

1 January 2011

1 reference

Journal of the International Association of Providers of AIDS Care

13 September 2017

published in

1 reference

13 September 2017

volume

10

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

57-63

1 reference

Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Impact of antiretroviral therapy on the relapse of cryptococcosis and survival of HIV-infected patients with cryptococcal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Effects of physician experience on costs and outcomes on an academic general medicine service: results of a trial of hospitalists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Do hospitalists or physicians with greater inpatient HIV experience improve HIV care in the era of highly active antiretroviral therapy? Results from a multicenter trial of academic hospitalists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Predictive factors of hyperlipidemia in HIV-infected subjects receiving lopinavir/ritonavir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

Lopinavir plasma concentrations and changes in lipid levels during salvage therapy with lopinavir/ritonavir-containing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109710387301

21 January 2018

Identifiers

DOI

10.1177/1545109710387301

1 reference

13 September 2017

1 reference